1/28
Comprehensive vocabulary flashcards covering the molecular mechanisms of RNAi and microRNA biogenesis, T cell activation and CAR-T engineering, cell cycle checkpoints and senescence, and programmed cell death pathways.
Dicer
An endoribonuclease that recognizes double-stranded RNA (dsRNA) and cleaves it into 21–23 nucleotide short-interfering RNAs (siRNAs), and cleaves cytoplasmic pre-miRNA into mature miRNA.
Short-interfering RNAs (siRNAs)
Double-stranded cleavage products of 21–23 nucleotides produced by Dicer that load into the RNA-induced silencing complex (RISC) to direct mRNA cleavage.
RNA-induced silencing complex (RISC)
A cytoplasmic complex loaded with siRNA or miRNA; its catalytic Argonaute protein discards the passenger strand and uses the guide strand to target complementary mRNA.
Argonaute
The catalytic protein within RISC that discards the passenger strand and uses the remaining guide strand to cleave perfectly complementary target mRNA, causing rapid degradation.
Drosha/Microprocessor complex
A nuclear enzyme complex that cleaves RNA Polymerase II-transcribed primary miRNA (pri-miRNA) into a hairpin precursor (pre-miRNA).
Pre-miRNA
A hairpin precursor RNA generated by the Drosha/Microprocessor complex in the nucleus, which is exported to the cytoplasm for cleavage by Dicer into mature miRNA.
MicroRNA (miRNA) Mechanism
Endogenously encoded small RNA that binds with imperfect complementarity to the 3' untranslated region (UTR) of target mRNAs, recruiting deadenylase complexes to shorten the polyA tail, destabilize mRNA, and repress translation.
Signal 1 (T Cell Activation)
The activation step where the T cell receptor (TCR) binds a peptide presented by MHC on an APC; co-receptors (CD4 or CD8) bind MHC, bringing kinase Lck to phosphorylate ITAMs on the CD3 complex, which recruits and activates ZAP-70.
Signal 2 (Co-stimulation)
The costimulatory signal required for full T cell activation and survival, occurring when CD28 on the T cell binds B7 (CD80/86) on the antigen-presenting cell.
Anergy
A state of immune unresponsiveness entered by a T cell when it receives Signal 1 through its TCR without receiving Signal 2 (co-stimulation).
Immune Checkpoints
Inhibitory receptors upregulated by T cells, such as CTLA-4 (which outcompetes CD28 for B7) and PD-1, that shut down the signaling cascade to prevent autoimmunity.
Chimeric Antigen Receptors (CARs)
Engineered receptors that fuse an antibody-derived extracellular single-chain variable fragment (scFv) with intracellular T cell signaling domains (typically CD3ζ plus CD28 or 4-1BB) to recognize surface antigens without MHC presentation.
Restriction Point (G1/S)
A critical cell cycle checkpoint where Cyclin D activates CDK4/6 to phosphorylate the retinoblastoma (Rb) protein, releasing E2F to drive transcription of genes required for S-phase.
Retinoblastoma (Rb) protein
A tumor suppressor protein that sequesters the E2F transcription factor until it is phosphorylated by Cyclin D-CDK4/6 complexes at the G1/S restriction point.
E2F
A transcription factor released from retinoblastoma (Rb) protein upon phosphorylation by CDK4/6 that activates the expression of genes needed for DNA replication in S-phase.
p53
A tumor suppressor stabilized by ATM/ATR kinases following double-strand breaks that acts as a transcription factor for p21 to halt the cell cycle for DNA repair.
p21
A Cyclin-dependent kinase inhibitor (CKI) transcribed by p53 in response to DNA damage that arrests the cell cycle to allow time for DNA repair.
Replicative Senescence
A permanent cell cycle arrest state maintained by p16 and p21, triggered when cellular damage is irreparable or telomeres become critically short.
Senescence-Associated Secretory Phenotype (SASP)
A secretory profile characteristic of metabolically active senescent cells, involving the secretion of pro-inflammatory cytokines, proteases, and growth factors.
Apoptosis
An immunologically silent programmed cell death mediated by caspases, divided into intrinsic and extrinsic pathways that converge on executioner Caspases-3 and -7.
Intrinsic Apoptotic Pathway
A caspase cascade triggered by internal stress (such as DNA damage) where Bax/Bak oligomerize on mitochondria, releasing cytochrome c to bind Apaf-1, forming the apoptosome and activating Caspase-9.
Apoptosome
A protein complex formed by cytochrome c binding to Apaf-1 in the cytoplasm during intrinsic apoptosis, responsible for activating initiator Caspase-9.
Extrinsic Apoptotic Pathway
A cell death pathway initiated by external death ligands (such as FasL) binding to death receptors, which assembles the DISC complex to activate initiator Caspase-8.
Necroptosis
A regulated form of inflammatory necrosis triggered when apoptosis is blocked, mediated by RIPK1 and RIPK3 necrosome formation that phosphorylates MLKL to rupture the plasma membrane.
MLKL
A downstream effector protein phosphorylated by RIPK1 and RIPK3 in the necrosome; upon phosphorylation, it oligomerizes and inserts into the plasma membrane, causing necrotic cell rupture.
Pyroptosis
A highly inflammatory cell death triggered by intracellular pathogens or danger signals, in which inflammasomes activate Caspase-1 (or Caspase-4/5/11) to cleave Gasdermin D.
Gasdermin D (GSDMD)
A substrate cleaved by inflammatory caspases during pyroptosis to liberate an N-terminal pore-forming domain that punctures the plasma membrane and releases IL-1β and IL-18.
Ferroptosis
An iron-dependent form of cell death driven by unchecked lipid peroxidation following GPX4 inhibition or glutathione depletion, which causes ROS accumulation on polyunsaturated fatty acids.
Glutathione Peroxidase 4 (GPX4)
An antioxidant enzyme whose inhibition or glutathione depletion triggers ferroptotic death via lethal accumulation of reactive oxygen species (ROS) on membrane polyunsaturated fatty acids.